Related Experiment Video
Updated: Jun 11, 2026

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
Laparoscopic resection for rectal cancer: a case-matched study
Andre da Luz Moreira1, Isabella Mor, Daniel P Geisler
1Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, A30, 9500 Euclid Avenue, Cleveland, OH 44195, USA. andreluzmoreira@yahoo.com.br
Laparoscopic surgery for rectal cancer offers better recovery and similar oncological outcomes compared to open surgery. This minimally invasive approach shows promise for improved patient outcomes in rectal cancer treatment.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Gastrointestinal Surgery
Background:
- Laparoscopic rectal cancer surgery is an evolving field.
- Comparison of laparoscopic versus open resection outcomes is crucial.
- Patient matching ensures reliable comparative analysis.
Purpose of the Study:
- To compare short-term outcomes of laparoscopic vs. open rectal cancer resection.
- To evaluate early oncological results between surgical approaches.
- To assess patient recovery metrics and complication rates.
Main Methods:
- 1:1 matched cohort study of laparoscopic and open rectal cancer resections.
- Matching criteria included age, gender, ASA class, BMI, neoadjuvant therapy, and surgery type.
- Statistical analysis utilized Fisher's exact, chi-square, Wilcoxon rank-sum tests, and Kaplan-Meier estimates.
Main Results:
- Laparoscopic surgery showed similar 30-day morbidity/mortality, but lower wound infection rates (p=0.02).
- Patients undergoing laparoscopic resection experienced shorter hospital stays (5 vs. 7 days, p<0.01) and faster return of bowel function.
- Similar 3-year disease-free survival, local recurrence, and distant recurrence rates were observed between groups.
Conclusions:
- Laparoscopic surgery is a safe option for rectal cancer treatment.
- It provides enhanced postoperative recovery and acceptable early oncological outcomes.
- Further data from ongoing randomized trials are needed for definitive long-term oncological assessment.
More Related Videos
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
06:46Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026